Moneycontrol PRO
Loans
Loans
HomeNewsDeepak shenoy of capitalmind.in

Deepak Shenoy Of Capitalmind.in

Jump to
  • Still a stock specific market; may correct little more: Experts

  • Prefer KEC International, Trident: Deepak Shenoy

    Deepak Shenoy of capitalmind.in is of the view that one may prefer KEC International and Trident.

  • SpiceJet more attractive than Jet Airways, Interglobe Aviation: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that SpiceJet is more attractive valuation wise as compared to Jet Airways and Interglobe.

  • Buy housing finance stocks on correction: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that one can buy housing finance stocks on correction.

  • Prefer Godrej Consumer, PI Industries: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in prefers Godrej Consumer and PI Industries.

  • Supreme Petro looks attractive, says Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that Supreme Petro continues to remain attractive.

  • Ujjivan Financial Services looks attractive: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that Ujjivan Financial Services looks attractive.

  • Positive on Hero Motocorp, Ashok Leyland: Deepak Shenoy

    Deepak Shenoy of capitalmind.in has a positive view on Hero Motocorp and Ashok Leyland.

  • Like Amara Raja Batteries, Supreme Industries: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in likes Amara Raja Batteries and Supreme Industries.

  • Prefer Maruti over Eicher Motors, Tata Motors: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that one may prefer Maruti Suzuki over Eicher Motors and Tata Motors.

  • Like Amara Raja Batteries, target Rs 930-940: Deepak Shenoy

    Deepak Shenoy of capitalmind.in likes Amara Raja Batteries for a target of Rs 930-940.

  • Prefer PVR, Aegis Logistics, Power Grid: Deepak Shenoy

    Deepak Shenoy of capitalmind.in is of the view that one may prefer PVR, Aegis Logistics and Power Grid.

  • See margin expansion for Asian Paints; remain a top pick: Pros

    The company's Q3 net profit jumped 25.8 percent to Rs 463 crore from Rs 368 crore in corresponding quarter last fiscal. However, exceptional hit partially mitigated profit growth.

  • Like Strides Arcolab for long term, says Deepak Shenoy

    Deepak Shenoy of Capitalmind.in likes Strides Arcolab for the long term.

  • Motherson Sumi Systems will outperform: Deepak Shenoy

    Deepak Shenoy of capitalmind.in is of the view that Motherson Sumi Systems will outperform.

  • Jindal Poly will perform in near term, says Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that Jindal Poly will perform in the near term.

  • Earnings watch: IT a good bet, say market experts

    Market expert, Ajay Bagga is bullish on largecap IT and expect them to report a 10-12 percent dollar guidance.

  • Positive on Sun Pharma, Strides Arcolab: Deepak Shenoy

    Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.

  • Like Larsen & Toubro, says Deepak Shenoy

    Deepak Shenoy of capitalmind.in likes Larsen & Toubro and is invested in the stock for a long time.

  • Keep BPCL, HPCL on long term radar: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that one can keep BPCL and HPCL in the long term radar.

  • Long on Sun Pharma, like midcap IT: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in is of the view that one may go long in Sun Pharma and Strides Arcolab and likes midcap IT space including Sterlite Technologies.

  • Like PVR, prefer Bharat Forge: Deepak Shenoy

    Deepak Shenoy of Capitalmind.in likes PVR and feels that one may prefer Bharat Forge.

  • Look at Aegis Logistics: Deepak Shenoy

    Deepak Shenoy of capitalmind.in is of the view that one may look at Aegis Logistics.

  • Prefer Just Dial: Deepak Shenoy

    Deepak Shenoy of capitalmind.in is of the view that one may prefer Just Dial.

  • Prefer Sun Pharmaceutical Industries: Deepak Shenoy

    Deepak Shenoy of capitalmind.in is of the view that one can purchase Sun Pharmaceutical Industries at the current level.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347